Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8007)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2016 (publication date) through Jan 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aroldi F, Bertocchi P, Savelli G, Rosso E, Zaniboni A. Pancreatic cancer: New hopes after first line treatment. World J Gastrointest Oncol 2016; 8(9): 682-687 [PMID: 27672426 DOI: 10.4251/wjgo.v8.i9.682] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i9/682.htm |
| Number | Citing Articles |
| 1 |
Elisabetta Malangone-Monaco, Yunes Doleh, Ashley Cole, Virginia Noxon, Giovanni Antico, Michael J. Pishvaian. The economic burden of metastatic pancreatic cancer. Pancreatology 2020; 20(7): 1434 doi: 10.1016/j.pan.2020.09.002
|
| 2 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
|
| 3 |
Sudarvizhi Thanigainathan, Sangamithra Ramalingan, Subramanianainar Meyyanathan, Basavan Babu. QbD Approach For Anti-Cancer Drugs - A Review. Current Pharmaceutical Analysis 2022; 18(3): 251 doi: 10.2174/1573412917666210531113243
|
| 4 |
Claudia Schmidt, Cornelia Loos, Lu Jin, Michael Schmiech, Christoph Q. Schmidt, Menna El Gaafary, Tatiana Syrovets, Thomas Simmet. Acetyl-lupeolic acid inhibits Akt signaling and induces apoptosis in chemoresistant prostate cancer cells in vitro and in vivo. Oncotarget 2017; 8(33): 55147 doi: 10.18632/oncotarget.19101
|
| 5 |
Nastaran Rezaei, Masoud Shahriari, Faramarz Mehrnejad. Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer. Journal of Drug Delivery Science and Technology 2023; 79: 104042 doi: 10.1016/j.jddst.2022.104042
|
| 6 |
Liangliang Lei, Jianguang Wang, Like Zhang, Yanbin Chen, Pengfei Yuan, Dechun Liu. Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for pancreatic cancer. Oncotarget 2017; 8(51): 89149 doi: 10.18632/oncotarget.20803
|
| 7 |
Fengbiao Guo, Jinping Li, Yaozhi Qi, Jianqing Hou, Haibin Chen, Shi-Wen Jiang. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01248-1
|
| 8 |
Xin Lu, Lirong Wang, Miao Li, Qi Zhou, Jue Jiang. Silencing NAF-1 represses the proliferation and motility of PDAC cells through inhibiting HIF-1α. Applied Nanoscience 2023; 13(4): 2977 doi: 10.1007/s13204-022-02360-6
|
| 9 |
Jonas R.M. Van Audenaerde, Jorrit De Waele, Elly Marcq, Jinthe Van Loenhout, Eva Lion, Johan M.J. Van den Bergh, Ralf Jesenofsky, Atsushi Masamune, Geert Roeyen, Patrick Pauwels, Filip Lardon, Marc Peeters, Evelien L.J. Smits. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells. Oncotarget 2017; 8(34): 56968 doi: 10.18632/oncotarget.18185
|
| 10 |
Therese Triemer, Alessandra Messikommer, Stella M. K. Glasauer, Jawad Alzeer, Miriam H. Paulisch, Nathan W. Luedtke. Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanism. Proceedings of the National Academy of Sciences 2018; 115(7) doi: 10.1073/pnas.1714790115
|
| 11 |
Byung Woog Kang, Ian Chau. Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials. Expert Opinion on Investigational Drugs 2021; 30(11): 1089 doi: 10.1080/13543784.2021.1995354
|
| 12 |
Jacob Vikström, Georgii Shangin, Tommi Viitanen, Natalja Eigeliene, Antti Jekunen. Real-World, Retrospective Data of Pancreatic Cancer Treatment Outcomes. Pancreas 2022; 51(2): e18 doi: 10.1097/MPA.0000000000001990
|
| 13 |
Shuai Hu, Yi Jin, Yanghan Liu, Mats Ljungman, Nouri Neamati. Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines. European Journal of Medicinal Chemistry 2018; 158: 884 doi: 10.1016/j.ejmech.2018.09.037
|
| 14 |
Fausto Petrelli, Alessandro Inno, Antonio Ghidini, Lorenza Rimassa, Gianluca Tomasello, Roberto Labianca, Sandro Barni. Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review. European Journal of Cancer 2017; 81: 174 doi: 10.1016/j.ejca.2017.05.025
|
| 15 |
Patrick L. Quinn, Donald Ohioma, Anja M.K. Jones, Sushil K. Ahlawat, Ravi J. Chokshi. Treatment of Rare and Aggressive Pancreatic Carcinosarcoma. ACG Case Reports Journal 2020; 7(5): e00379 doi: 10.14309/crj.0000000000000379
|
| 16 |
Linas J. Krulikas, Ian M. McDonald, Benjamin Lee, Denis O. Okumu, Michael P. East, Thomas S.K. Gilbert, Laura E. Herring, Brian T. Golitz, Carrow I. Wells, Allison D. Axtman, William J. Zuercher, Timothy M. Willson, Dmitri Kireev, Jen Jen Yeh, Gary L. Johnson, Antonio T. Baines, Lee M. Graves. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. SLAS Discovery 2018; 23(8): 850 doi: 10.1177/2472555218773045
|
| 17 |
Gui‐Feng Liu, Gui‐Jie Li, Hang Zhao. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta‐Analysis. Journal of Cellular Biochemistry 2018; 119(1): 511 doi: 10.1002/jcb.26210
|
| 18 |
Xiu Hu, Wei Chen. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma. World Journal of Clinical Cases 2021; 9(19): 4998-5006 doi: 10.12998/wjcc.v9.i19.4998
|
| 19 |
Tianying Zheng, Wenfei Han, Aijun Wang, Yonggang Wang. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. PeerJ 2022; 10: e12802 doi: 10.7717/peerj.12802
|